A pilot study of oxaliplatin, irinotecan and PK-adjusted 5-fluorouracil within a neoadjuvant multidisciplinary approach in locally advanced pancreatic cancer patients.

Authors:

Abstract
E15220 Background: The aim of this study was to evaluate the feasibility and efficacy of FOLFOXIRI induction chemotherapy (ICT) with pharmacokinetic (PK) dose adjustment of 5-FU followed by chemo-radiotherapy (CRT) and surgery (S) in Locally Advanced Pancreatic Cancer patients (pts) Methods: Borderline resectable and unresectableLAPC pts with EUS stages T3-4/N+ were included. ICT consisted of 4 cycles of Oxalipatin (85mg/m²), Leucovorin (400mg/m²), Irinotecan (150mg/m²) and 5-FU [initial dose of 3200mg/m² in 46h; subsequent doses based on PK-guided dose adjustments (therapeutic AUC of 20-30 mg∙h∙L-1)]. 5-FU concentrations were analyzed by High-performanced Liquid Chromatography. PK parameters were estimated by Bayesian Methodology with Multiple Dose Software. Pts with no progressive disease after ICT were planned to receive CRT. Surgery (S) was planned 4 to 6 weeks after completion of CRT. Toxicity was recorded according to the NCI-CTCAE 4.0 Results:From November 2011 to August 2014, 23 LAPC treatment-naï...